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Copyright © 200? JCBN 200? This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Coenzyme Q10 is an essential cofactor in the respiratory chain and
serves as a potent antioxidant in biological membranes. Recent
studies in vitro and in vivo provide evidence that Coenzyme Q10
is involved in inflammatory processes and lipid metabolism via
gene expression. To study these effects at the epigenomic level,
C57BL6J mice were supplemented for one week with reduced
Coenzyme Q10 (ubiquinol). Afterwards, gene expression signatures
and DNA promoter methylation patterns of selected genes were
analysed. Genome wide transcript profiling in the liver identified
1112 up regulated and 571 down regulated transcripts as differ 
entially regulated between ubiquinol treated and control animals.
Text mining and GeneOntology analysis revealed that the “top
20” ubiquinol regulated genes play a role in lipid metabolism and
are functionally connected by the PPARα signalling pathway. With
regard to the ubiquinol induced changes in gene expression of
about +3.14 fold (p≤0.05), +2.18 fold (p≤0.01), and −2.13 fold
(p≤0.05) for ABCA1, ACYP1, and ACSL1 genes, respectively, hepatic
DNA methylation analysis of 282 (sense orientation) and 271
(antisense) CpG units in the respective promoter islands revealed
no significant effect of ubiquinol. In conclusion, ubiquinol affects
the expression of genes involved in PPARα signalling and lipid
metabolism without changing the promoter DNA methylation
status in the liver of mice.
Key Words: ubiquinol, inflammation, lipid metabolism, 
methylation, gene expression
Introduction Coenzyme Q10 (CoQ10) is an important cofactor in the respira-
tory chain. The reduced form of Coenzyme Q10 (ubiquinol)
serves as a potent antioxidant in mitochondria and lipid.(1) More
recently, studies in vitro,(2,3) in SAMP1 mice(4) and in humans(5)
provide evidence that ubiquinol is involved in inflammatory pro-
cesses and lipid metabolism via gene expression. Moreover,
reducing effects of coenzyme Q10 (ubiquinone) have been also
described on genes involved in inflammation and hepatic stress-
associated processes in the liver of diet-induced obese mice.(6)
However, when related to the oxidized form of coenzyme Q10
(ubiquinone), stronger effects have been observed for the reduced
form (ubiquinol) both on the transcriptional(4,7) or protein level(8,9)
in vitro and in vivo. To study the observed transcriptional effects of
reduced coenzyme Q10 (ubiquinol) in more mechanistic detail,
C57BL6J mice were supplemented for one week with 250 mg/kg
BW/d ubiquinol. Afterwards, the resulting gene expression signa-
tures were analyzed in the liver of mice, and DNA methylation
patterns within the promoters of regulated genes were evaluated.
Epigenetic mechanisms such as DNA methylation have been
shown to entail heritable changes in gene expression.(10,11) Of
note, impacts on DNA methylation processes have been already
described for various dietary supplements and food nutrients so
far.(12,13) DNA methylation consists of the addition of a methyl
group to the fifth carbon-position of the cytosine pyrimidine ring
in the context of a CpG dinucleotide. Although most genomic
DNA in mammals is deficient in CpG sites, clusters of CpG
dinucleotides (CpG islands) were described to be primarily
located in promoter regions of genes.(14) Thus, the present study
postulates that ubiquinol affects gene expression by modulating
DNA methylation patterns in the respective CpG island promoter
regions of the selected genes.
Materials and Methods
Animals and diet. C57BL6J mice were reared in the Bio-
chemical and Medical Research Laboratories, KANEKA Corp.
(Takasago, Japan), at 22 ± 2°C and a 12 h-light-dark cycle. Water
and food intake were available ad libitum. At the beginning of
the short-term supplementation study, eight 10-week old male
C57BL6J mice were purchased from Charles River Lab. Inc.
(Yokohama, Japan). To avoid fighting, mice were housed separately
throughout 1-week acclimation period and ubiquinol-supplemen-
tation study. In the initial phase of the experiment, C57BL6J mice
were randomly assigned to either the ubiquinol (n = 4) or control
group (n = 4). Ubiquinol (KANEKA, QHTM) was added to a
standard laboratory mouse diet (powdered CE-2, CLEA, Osaka,
Japan) at a concentration of 0.2% with corn oil (1%, v/w). The
only corn oil (1%, v/w) was used as a vehicle in the control diet.
The mixture was incorporated in pellet-type chow by adding 30%
ethanol solution (v/v), pressure shaping and drying. In general,
body weights and food consumption of the mice were calculated
every second day, while mice were inspected daily. After 7-day
supplementation period with ubiquinol or the respective control
diet, animals were sacrificed by anesthesia using isoflurane gas.
Livers were removed and the outer left lobes were stored in RNA-
later Storage Solution (Qiagen, Tokyo, Japan) until use for gene
expression and methylation analyses.
Microarray analysis. Microarray analysis was conducted on
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four samples for each group, respectively, by using GeneChip®
Mouse Genome 430 2.0 Array (Affymetrix, High Wycombe,
United Kingdom) containing 45,100 probe sets. Initially, total
RNA was extracted from liver tissues with the miRNeasy kit
(Qiagen, Hilden, Germany). The following procedure was per-
formed according to manufacturer’s instructions using Poly-A
RNA Control Kit (Affymetrix) and One-Cycle cDNA Synthesis
Kit (Affymetrix) for cDNA synthesis, Sample Cleanup Module
(Affymetrix) for purification, and IVT Labeling Kit (Affymetrix)
for synthesis of biotin-labeled cRNA. Fifteen μg of fragmented
cRNA was hybridized to a Mouse Genome 430 2.0 Array for 16 h
at 45°C at 60 rpm. Subsequently thereafter, arrays were washed
and stained using Fluidics Station 450. Hybridization, washing
and staining solutions were obtained from analogous GeneChip®
kits. After hybridization and washing procedures, microarrays
were scanned with the GeneChip® scanner 3000, using GCOS
software. If not stated otherwise, all kits and equipment were
purchased from Affymetrix. Fluorescence data were obtained
in CEL file format. Quality control and normalization procedure
of the files was performed with R software 2.7.1 and BioCon-
ductor 2.0.1 provided by the MADMAX database (https://
madmax.bioinformatics.nl). Data were normalized with the GC-
RMA algorithm. Only probe sets showing present calls for all
arrays at one experimental group (intervention or control) were
considered for further analysis. The complete datasets will be
submitted to NCBI Gene Expression Omnibus (GEO).
qRT PCR. Primer sequences for real-time quantitative RT-
PCR (qRT-PCR) experiments were designed with Primer Express®
Software 3.0 (Applied Biosystems, Darmstadt, Germany). Primer
pairs (5'-3') for NELF (forward: GAACCCCGAGCCGAATG,
reverse: CCGTTAGGGTTCCCCAGAAT) and GPX3 (forward:
ACAGGAGCCAGGCGAGAA, reverse: CCACCTGGTCGAA-
CATACTTGA) were obtained from MWG Biotech AG (Ebersberg,
Germany). cDNA synthesis was initially carried out with the
reverse transcriptase core kit (Eurogentec, Köln, Germany) on a
thermocycler (Biometra, Göttingen, Germany). qRT-PCR amplifi-
cation was performed with the Power SYBR® Green PCR Master
Mix (Applied Biosystems, Darmstadt, Germany) on an Applied
Biosystem 7300 qRT-PCR system. Ct-values of target genes were
related to those of the corresponding housekeeping gene glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH).
Text mining analysis. For analysis of common pathways
between regulated genes, Genomatix software 2010 (www.
genomatix.de) was used. Probe set IDs of the selected genes were
uploaded to BibliospherePathwayEdition (BSPE) software. This
text mining tool identifies putative functional connections of
genes based on co-citations with transcription factors and other
genes in the network from NCBI PubMed. The most stringent
co-citation filter restricted to sentences with expert curated infor-
mation (level B4) was applied.
Promoter DNA methylation analysis. The presence of CpG
islands within the ABCA1, ACSL1 and ACYP1 gene promoters
was predicted by EMBOSS CpGplot program. Quantitative
methylation analysis of the three genes was performed with the
MassARRAY® system (Sequenom, Hamburg, Germany). The
MassCLEAVETM biochemistry was applied after bisulfite treat-
ment of DNA samples and MALDI-TOF mass spectrometry for
analyte detection according to the standard protocols recommended
by the supplier. Genomic DNA was extracted from mice liver with
the DNeasy Kit (Qiagen). One microgram DNA was treated with
sodium bisulfate (DNA Bisulfite Treatment Kit, Sequenom,
Hamburg, Germany) and target regions of the modified nucleic
acid were amplified by PCR using methylation independent
primers, designed by the MassARRAY platform specific
EpiDesigner software (Table 2). The PCR products were then
subjected to in vitro transcription with RNase A cleavage being
used for the T-reverse reaction (Sequenom). The generated frag-
ments were displayed based on their molecular weight in the mass
spectrum, which was acquired after sample conditioning with a
MassARRAY® Analyzer Compact. The resulting methylation
calls were analyzed with EpiTyper Software (Sequenom) to
generate quantitative results for each CpG site.
Statistics. If not stated otherwise, data are expressed as
means ± SEM of four mice per each group, respectively. Differ-
ences between ubiquinol-treated and non-treated animals were
analyzed by an unpaired two-tailed Students t test. p values less
than or equal to 0.05 were considered as significant.
Results and Discussion
Ubiquinol supplementation reveals no impact on body
weight changes. Eight male C57BL6J mice were received at
the age of 10 weeks, and initially maintained for 1-week acclima-
tion period. Immediately thereafter, mice were randomly grouped
(n = 4 for each group) and either supplemented with ubiquinol
(250 mg/kg/d) or a respective control diet for one week. As
indicated in Fig. 1, body weights slightly increased both in the
subsequently treated ubiquinol group and in control animals
during acclimation period from day 1 (−6) to day 7 (0) from
22.15 ± 0.26 g and 22.68 ± 0.44 g to 22.9 ± 0.29 g (p = 0.0032)
and 23.53 ± 0.60 g, respectively. Increases in body weights were
obtained during grouping period (from day 0 to day 1) in both
groups with total values of 24.43 ± 0.25 g in the ubiquinol group
and 24.38 ± 0.11 g in control animals. No significant changes of
body weights have been found during supplementation period
from day 1 until sacrifice of mice (day 8) both in ubiquinol-treated
and control animals. The final body weights were 25.15 ± 0.15 g
and 24.73 ± 0.34 for treatment and control animals, respectively,
and are thus comparable to age-matched C57BL6J mice described
in the literature.(6) Finally, at any indicated time point, no signifi-
cant differences in body weights were found between treatment
and control group. Hence, subsequently described effects of
ubiquinol supplementation on gene expression and promoter
methylation patterns cannot be simply ascribed to changes in weight.
Whole genome expression data reveal effects of ubiqui 
nol supplementation on liver lipid metabolism. Microarray-
based whole genome expression profiles were analyzed from liver
samples of mice either supplemented with ubiquinol (250 mg/kg
Fig. 1. Body weight development of 10 week old C57BL6J mice
during acclimation period and one week supplementation period with
ubiquinol (250 mg/kg/d) or a respective control diet. Body weights of
Q10H2 treated and control animals increased slightly during acclimation
period (from day 1 [−6] to day 7 [0]). Strong increases in body weights
were obtained during grouping period (from day 0 to day 1) in both
groups. No significant changes of body weights have been found
during supplementation period from day 1 until sacrifice of mice (day 8)
both in the ubquinol treated (+Q10H2) and control group (−Q10H2). J. Clin. Biochem. Nutr. | March 2012 | vol. 50 | no. 2 | 121
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body weight/d) or a respective control diet for one week. Samples
were taken from four mice per each group respectively, resulting
in a total of eight microarrays. Differentially expressed genes
between ubiquinol-treated and control animals were selected as
follows: Initially transcripts with at least four present calls (100%)
in one group (treatment or control) were chosen for further
analysis. Secondly, transcripts showing at least a 1.5-fold increase
or decrease in the ubiquinol-treated animals when related to
controls (p≤0.05, Students t test) were selected. Based on these
criteria, 1112 and 571 transcripts were up- and down-regulated by
ubiquinol, respectively. To study the observed effects of ubiquinol
supplementation on gene expression in more detail, transcripts
with the highest fold change values (“Top 20”, p≤0.05) were
selected. However, before unravelling putative functional connec-
tions among these genes, the accuracy of microarray data was
verified by qRT-PCR for two selected “top 20” genes, namely
glutathione peroxidase 3 (GPX3) and nasal embryonic LHRH
factor (NELF) (Fig. 2). In brief, GPX3 has been described to
mediate PPARγ-associated antioxidant effects in human muscle
cells and plasma.(15) Additionally, an influence on the regulation of
Fig. 2. Verification of selected “top 20” genes from microarray experiments by qRT PCR. For verification of microarray data, two “top 20” up 
regulated genes (GPX3, NELF) were further selected for qRT PCR experiments. Finally, GPX3 (A) and NELF (B) genes were up regulated about 2.0 
fold (p = 0.0196) and 1.3 fold (p = 0.026) in the ubiquinol treated (+Q10H2) animals, respectively, when related to control mice (−Q10H2).
Fig. 3. Bibliosphere network of ubiquinol sensitive genes regulated in liver tissues of C57BL6J mice. Based on co citations with transcription fac 
tors and other genes in the network (GFG level B4), 3 ubiquinol inducible genes were connected with each other by BibliospherePathwayEdition
Software. According to this, the uploaded genes seem to play a key role in PPAR α signalling pathways. IN, input gene; TF, transcription factor; M,
gene product is part of a metabolic pathway; ST, gene product is part of a Genomatix signal transduction pathway.doi: 10.3164/jcbn.11 19
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Table 1. Display of the “top 20” up  and down regulated genes in liver samples of mice supplemented with ubiquinol for 7 days
# presented by ≥2 probe set Ids in Top 20 gene list.
Affymetrix Probe Set ID FC p value Gene symbol Gene name GeneOntology Process/Function
up regulated genes
1451488_at 6.67 0.04 FITM1 fat storage inducing transmembrane 
protein 1
Lipid particle organization, positive regulation of sequestering of 
triglyceride
1439398_x_at 5.82 0.0001 Nelf Nasal embryonic LHRH factor
1452637_a_at 5.09 0.02 Bola1 Bola like 1 (E. coli) biological process, molecular function
1428554_a_at 4.59 0.04 1810035L17Rik RIKEN cDNA 1810035L17 gene Biological process, regulation of transcription, RNA binding, molecular 
function, nucleic acid binding, nucleotide binding
1416439_at 4.57 0.01 Dctpp1 dCTP pyrophosphatase 1 Nucleoside triphosphate catabolic process, protein homotetramerization, 
dCTP diphosphatase activity, hydrolase activity, metal ion binding
1428464_at 4.48 0.05 Ndufa3 NADH dehydrogenase (ubiquinone) 1 
alpha subcomplex, 3
Biological process, electron transport chain, transport, molecular function
1420952_at 4.26 0.04 Son Son cell proliferation protein DNA binding, RNA binding, nucleic acid binding, protein binding
1438403_s_at 4.24 0.04 — —
1422608_at 4.14 0.02 Arpp19 cAMP regulated phosphoprotein 19 positive regulation of Ras protein signal transduction, molecular function
1449106_at 4.1 0.05 Gpx3 glutathione peroxidase 3 Glutathione metabolic process, hydrogen peroxide metabolic process, 
oxidation reduction, response to oxidative stress, glutathione binding, 
peroxidase activity, oxidoreductase activity
1421374_a_at 4.01 0.03 Fxyd1 FXYD domain containing ion transport 
regulator 1
Cellular calcium ion homeostasis, ion transport, muscle contraction, 
transport, chloride channel activity, ion channel activity
1416217_a_at 4 0.05 Rpl37a ribosomal protein L37a biological process, molecular function
1434823_x_at 3.91 0.02 Myeov2 myeloma overexpressed 2 biological process, molecular function
1436757_a_at 3.91 0.03 Cox6b1 cytochrome c oxidase, subunit VIb 
polypeptide 1
cytochrome c oxidase activity
1420642_a_at 3.91 0.05 Romo1 reactive oxygen species modulator 1 biological process, molecular function
1448685_at 3.88 0.04 2900010M23Rik RIKEN cDNA 2900010M23 gene biological process, molecular function
1438655_a_at 3.86 0.04 Rpl34 ribosomal protein L34 biological process, molecular function
1431199_at 3.84 0.04 Ggnbp1 gametogenetin binding protein 1 Cell differentiation, mitochondrial fission, multicellular organismal 
development, spermatogenesis, protein binding
1416285_at 3.82 0.04 Ndufc1 NADH dehydrogenase (ubiquinone) 1, 
subcomplex unknown, 1
biological process, electron transport chain, transport, molecular function
1429453_a_at 3.8 0.02 Mrpl55 mitochondrial ribosomal protein L55 biological process, molecular function
down regulated genes
1452391_at –3.37 0.002 Cxadr Coxsackie virus and adenovirus receptor cardiac muscle fiber development, cell adhesion, cell cell junction 
organization, heart development, mitochondrial organization, 
negative regulation of cardiac muscle cell proliferation, protein 
binding, receptor activity
1450392_at –3.15 0.02 Abca1 ATP binding cassette, sub family A 
(ABC1), member 1
cholesterol efflux, cholesterol transport, lipoprotein biosynthetic process, 
phospholipids efflux, positive regulation of cholesterol efflux, protein 
amino acid lipidation, ATP binding, ATPase activity, cholesterol 
transporter activity
1427408_a_at –2.91 0.02 Thrap3 thyroid hormone receptor associated 
protein 3
positive regulation of transcription from RNA polymerase II promoter, 
transcription coactivator activity
1417015_at –2.84 0.04 Rassf3 Ras association (RalGDS/AF 6) domain 
family 3
biological process, signal transduction, molecular function, protein 
binding
AFFX PyruCarbMur/
L09192_5_at
–2.7 0.04 Pcx pyruvate carboxylase gluconeogenesis, lipid biosynthetic process, metabolic process, 
oxaloacetate metabolic process, pyruvate metabolic process, ATP 
binding, biotin binding, metal ion binding, pyruvate carboxylase 
activity, nucleotide binding
1425461_at –2.67 0.02 Fbxw11 F box and WD 40 domain protein 11 Wnt receptor signalling pathway, biological process, cell cycle, rhythmic 
process, molecular function
1420948_s_at –2.61 0.002 Atrx alpha thalassemia/mental retardation 
syndrome X linked homolog (human)
DNA repair, forebrain development, response to DNA damage stimulus, 
ATP binding, DNA binding, chromatin binding, metal ion binding
1433515_s_at –2.6 0.01 Etnk1 ethanolamine kinase 1 biological process, phospholipid biosynthetic process, ATP binding, 
ethanolamine kinase activity, kinase activity, molecular function, 
nucleotide binding, transferase activity
1425834_a_at –2.6 0.05 Gpam glycerol 3 phosphate acyltransferase, 
mitochondrial
Acyl CoA metabolic process, cellular response to insulin stimulus, 
defense response, fatty acid homeostasis, glycerophospholipid 
metabolic process, triglyceride metabolic process, phospholipid 
homeostasis, regulation of cytokine secretion, acyltransferase activity
1430991_at –2.56 0.03 1810014B01Rik RIKEN cDNA 1810014B01 gene biological process, molecular function
1424484_at –2.55 0.04 Mobkl1b MOB1, Mps One Binder kinase activator 
like 1B (yeast)
metal ion binding, protein binding
1448158_at –2.49 0.04 Sdc1 syndecan 1 canonical Wnt receptor signaling pathway, myoblast development, 
cytoskeletal protein binding, glycoprotein binding
1422862_at –2.45 0.02 LOC669660 similar to PDZ and LIM domain protein 
5 (Enigma homolog) 
(Enigma like PDZ and LIM domains protein)
1420864_at –2.43 0.0003 Zfp161 zinc finger protein 161 Regulation of transcription, DNA binding, metal ion binding, 
nucleic acid binding, protein binding, zinc ion binding
1415965_at –2.4 0.004 Scd1 stearoyl Coenzyme A desaturase 1 Brown fat cell differentiation, cholesterol esterification, fatty acid 
biosynthetic process, lipid metabolic process, oxidation reduction, 
white fat cell differentiation, oxidoreductase activity, stearoyl CoA9 
desaturase activity, iron ion binding
1431096_at –2.4 0.04 Ints8 integrator complex subunit 8 biological process, molecular function
1419816_s_at –2.39 0.004 Errfi1 ERBB receptor feedback inhibitor 1 lung alveolus development, negative regulation of epidermal growth 
factor receptor activity, regulation of keratinocyte differentiation, 
stress activated protein kinase signalling cascade, kinase binding, 
protein binding, receptor activity
1420927_at –2.38 0.03 St6gal1 beta galactoside alpha 2,6 sialyltransfer 
ase 1
metabolic process, protein amino acid glycosylation, sialyltransferase 
activity
1448607_at –2.37 0.004 Nampt nicotinamide phosphoribosyltransferase NAD biosynthetic process, positive regulation of muscle cell 
proliferation, pyridine nucleotide biosynthetic process, cytokine 
activity, nicotinamide phosphoribosyltransferase activity, protein 
homodimerization activity
1418279_a_at –2.36 0.01 Akap1 A kinase (PRKA) anchor protein 1 Negative regulation of NFAT protein import into nucleus, negative 
regulation of protein amino acid dephosphorylation, RNA binding, 
kinase activity, nucleic acid binding J. Clin. Biochem. Nutr. | March 2012 | vol. 50 | no. 2 | 123
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local and systemic oxidative stress processes has been described.(16)
In this context, effects of ubiquinol supplementation on hepatic
oxidative stress-associated gene regulation has been already
described previously.(6) The NELF gene is primarily expressed
in olfactory sensory cells and LHRH cells during embryonic
development,(17) and is therefore ascribed as an important factor in
the developmental migration process. In adult tissue, NELF has
been also shown to be present in the liver.(17) In summary we could
show that the fold change values of the two selected “top 20”
genes glutathione peroxidase 3 (GPX3) and nasal embryonic
LHRH factor (NELF) (Fig. 2) were in accordance to the micro-
array data (Table 1). To determine functional connections between
the “top 20” up- and down-regulated genes, text mining analysis
was subsequently performed by the use of Genomatix Biblio-
spherePathwayEdition Software including GFG level B4. Based
on these stringent criteria, three ubiquinol-sensitive genes [ATP-
binding cassette, sub-family A (ABC1), member (ABCA1),
stearoyl-Coenzyme A desaturase 1 (SCD1) and glycerol-3-phos-
phate acyltransferase (GPAM)] were functionally connected with
each other in the PPARα signalling pathway (Fig. 3). Moreover,
when related to GeneOntology terms (Table 1), 6 (15%) of the
“top 20” up- and down-regulated genes were related to cholesterol
or lipid metabolism. These results suggest a functional role of
ubiquinol in cholesterol and/or lipid metabolism and are, inter alia
in agreement to a previous performed supplementation study with
ubiquinol in senescence accelerated mice prone (SAMP1). In this
Table 2. PCR primers for analysis of the methylation status of (A) ABCA1, (B) ACSL1 and (C) ACYP1 gene promoters. All positions are relative to the
entire input sequences
(A) ABCA1
amplicon primer
start end length CpGs left right
forward direction
ABCA1_amp01 50 506 457 8 GGTTTTTGGAAGGTAGAGATTTTTT CCCTAACCCTAACCTACTAACCTTC
ABCA1_amp02 482 1101 620 40 GAAGGTTAGTAGGTTAGGGTTAGGG CCCTATACTATTTACATCCCCAAAAA
ABCA1_amp03 1076 1515 440 21 TTTTTGGGGATGTAAATAGTATAGGG CCCAAAAAACTCAAACAACAATAAC
ABCA1_amp04 1424 1967 544 22 GATTGGGATTGTATGTTTTTGTTTT CACCAATTTTAACCAAATTCACAAT
reverse direction
ABCA1_amp05 115 516 402 8 TTTTTTGTAGTTTTGGTTTTGATTTG AAACTAATATTCACTATCCATTCCACA
ABCA1_amp06 491 891 401 36 GGGGGAAATAGGGAGTAGAGTAGTT CAAATCAAAACCAAAACTACAAAAA
ABCA1_amp07 865 1367 503 23 AGGATTTAGATGTGATATTTGTGGG AAAACTACTCTACTCCCTATTTCCCC
ABCA1_amp08 1343 1669 327 7 AGGGTGGATTGGGTATTTTAGTTT CCCACAAATATCACATCTAAATCCT
ABCA1_amp09 1646 2084 439 17 GGTTTGGGAGTTAGGAAATAAATAAA AAACTAAAATACCCAATCCACCCT
(B) ACSL1
amplicon primer
start end length CpGs left right
forward direction
ACSL1_amp01 27 390 364 13 AGGATGGAAGAGTTAAAGGGTATTT TATCTAAACTAATCCAAACCCCTCA
ACSL1_amp02 366 1078 713 78 TGAGGGGTTTGGATTAGTTTAGATA CAAAATCCCCAACAAACAAAA
ACSL1_amp03 1049 1278 230 22 GAGAGGTGGTTTTGTTTGTTGG TCTAAAAACTCCTCTTAAAAACACC
reverse direction
ACSL1_amp04 87 387 301 13 TTGGGTTGATTTAAGTTTTTTAGATT AAAACTTCCAAATTTACCCTTTACC
ACSL1_amp05 364 1077 714 78 AGGGTTTTTAGTAAGTAGGATTATTTTT TCTAAAAAACTTAAATCAACCCAAA
ACSL1_amp06 1050 1290 241 22 GTGTGTAGTGGTTTTGGGAGTTT AAAAATAATCCTACTTACTAAAAACCCT
(C) ACYP1
amplicon primer
start end length CpGs left right
Region 01
forward direction
ACYP1_amp01 142 729 588 29 GAGAGGGGGTGATAGATATTTGAG AATATAACCCCAAAAAAACCTCTCC
ACYP1_amp02 767 945 179 7 AGATTTTAGGGTGTGTTTTTGTTTG CCTAAAACTCTTACATAACCCTACCT
reverse direction
ACYP1_amp03 76 355 280 12 TGGGGATTTTTTTTGAGTTGGAG TCAAACCCTCATACAAAAATACTCTAT
ACYP1_amp04 344 943 600 26 TGGAGTTTTTATATAGTTTTATTTGGGG AAAAAATCCCCAAAACCTAATTTTC
Region 02
forward direction
ACYP1_amp05 11 394 384 16 TTTTAGGTATTTAGTAGGGTGAGTGGA ATTTCTAAAACTTCCCCAAAAACC
ACYP1_amp06 195 599 405 26 ATTTGTTTTGAAGTTTTATTTTTGGG CTCCAATACCATAAAAACCTCTCC
reverse direction
ACYP1_amp07 1 601 601 29 TTTTTTAATATTATGGGGGTTTTTT ATACTAACAACCCTAAACACCCAAdoi: 10.3164/jcbn.11 19
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study, various genes with a functional role in cholesterol synthesis,
fat assimilation and lipoprotein metabolism have been shown to
be affected.(4) Moreover, these transcriptional effects were also
translated into physiological readouts of cholesterol metabolism in
vivo.(18) In summary, our present and previous data show both short
and long-term effects of ubiquinol supplementation on genes
involved in liver lipid and/or cholesterol metabolism.
Ubiquinol induced effects on gene expression are not
mediated by changes in promoter methylation. With regard
to the functional analysis of the microarray data from liver tissues
of ubiquinol-supplemented mice, distinct effects on genes related
to lipid and/or cholesterol metabolism were found (Table 1,
Fig. 3). Because transcriptional variation has been correlated
with CpG island variation(19) and previous literature reports have
documented distinct roles of various micronutrients in the
epigenetic regulation of gene expression,(20–23) CpG island regions
in promoter regions of three regulated genes strongly related to
lipid metabolism were analyzed for putative changes by using
base-specific cleavage and matrix-assisted laser desorption ioniza-
tion time-of-flight (MALDI-TOF) mass spectrometry. In general,
as an essential precondition, all three genes show CpG islands in
their promoter regions and could be therefore selected for DNA
methylation analysis. Based on these criteria and the results from
microarray experiments, the following ubiquinol-regulated genes
(p≤0.05) were finally selected for subsequent methylation analysis:
ABCA1 (ATP-binding cassette, sub-family A, member 1), ACSL1
(Acyl-CoA Synthetase long-chain family member 1) and ACYP1
(Acylphosphatase 1). These genes have been shown to be regu-
lated about +3.14-fold (p≤0.05), −2.13-fold (p≤0.05) and +2.18-
fold (p≤0.01), respectively, when related to liver samples of
control mice. In brief, the ABCA1 gene is a LXR target gene
and plays an important role in reverse cholesterol transport.(24)
ACSL1 plays an important role in fatty acid metabolism and
triacylglycerol synthesis.(25) Disturbances of these pathways may
result in e.g. dyslipidemia, one hallmark of the metabolic
syndrome.(26) ACYP1 primarily mediates hydrolytic activity on
e.g. acyl phosphates and aryl phosphate monoesters.(27) Overall,
our DNA methylation analysis at 282 (sense orientation) and 271
(antisense orientation) CpG units, spanning nucleotides relatively
to the gene start position from −748 to 1,391 for ABCA1 gene
(Fig. 4A), from −552 to 819 for ACSL1 gene (Fig. 4B), and from
−6,863 to –7,663 as well as −298 to 336 for ACYP1 gene (Fig. 4C)
revealed no differences between Q10H2-treated and control animals.
From these results, no significant differences in the promoter
methylation patterns of ABCA1, ACSL1 and ACYP1 genes could
be detected with regard to a short term supplementation period
with ubiquinol in C57BL6J mice.
Although we could not found any significant effects of
Fig. 4. Schematic overview of amplicons processed for ABCA1 (A), ACSL1 (B) and ACYP1 (C) analyses in the genomic context. Positions are relative
to the selected input region (indicated as reg) and correspond to Table 2 for each respective gene. The regions are located for ABCA1 (A) and ACSL1
(B) gene at position −748 to 1391 and −552 to 819, respectively, when related to the gene start position. For ACYP1 gene (C), region 01 (upper por 
tion) and region 02 (lower portion) are located at position −6863 to −7663 and −298 to 336, respectively, when related to the gene start position. All
genes are shown in their transcribed orientation, which is located for ABCA1 and ACYP1 on the antisense strand of chromosome 4 and 12, respec 
tively. For ACSL1 gene, the transcribed orientation is shown on the sense strand of chromosome 8. J. Clin. Biochem. Nutr. | March 2012 | vol. 50 | no. 2 | 125
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ubiquinol supplementation on CpG island promoter region
methylation patterns of ABCA1, ACSL1 and ACYP1 genes,
previous results in the literature show that coenzyme Q10
containing coenzyme supplementation is able to induce the
disappearance of tamoxifen-induced RASSF1A DNA methylation
patterns in breast cancer patients.(28) Moreover, this supplementary
therapy has also been shown to counteract the tamoxifen-induced
increased lipoprotein and lipid levels in these patients.(28) By the
way, ubiquinol-induced reductions of LDL cholesterol levels
have been also observed previously in healthy male volunteers.(5)
From these results it seems that ubiquinol supplementation may
modulate lipid metabolism through an impact on DNA methyla-
tion patterns. Although we could not find any ubiquinol-induced
supplementary effects in the present study, it can not be ruled out
that changes in the methylation pattern other than in the promoter
region of ABCA1, ACSL1 and ACYP1 genes have led to the
observed differences on gene expression. In fact, effects on global
methylation patterns have been already described for several other
dietary supplements and micronutrients in the literature.(20,21,29–32)
Thus, a global methylation analysis would be required to finally
answer the question of a ubiquinol-dependent epigenetic regula-
tion of ABCA1, ACSL1 and ACYP1 genes. Moreover, the
observed changes in gene expression might be also mediated
through modifications of histones by acetylation, methylation,
phosphorylation, ubiquitination, sumoylation or isomerisation.(22,23)
The ability of dietary compounds to influence epigenetic pro-
cesses via histone modification has been already described in vitro
and in vivo.(32,33) However, the translation of these findings into
clinical health applications is still a remaining challenge for
further studies in the future.
In summary, we could show that one-week supplementation
with ubiquinol (250 mg/kg BW/d) induces a gene expression
pattern in liver tissues of C57BL6J mice with a functional role in
PPARα signalling, lipid and/or cholesterol metabolism. Because
transcriptional variation has been correlated with CpG island
variation, CpG island regions in promoter regions of three regu-
lated genes (ABCA1, ACSL1 and ACYP1) with a relevant impact
in lipid and/or cholesterol metabolism were analyzed. However,
promoter DNA methylation analysis of ABCA1, ACSL1 and
ACYP1 promoters in the liver of C57BL6J mice revealed no
differences between ubiquinol-treated and control mice. Thus,
ubiquinol affects the expression of genes involved in PPARα
signalling and lipid metabolism without changes in promoter
DNA methylation in the liver of mice.
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Fig. 5. Epigram of quantitative methylation analysis of promoter regions in ABCA1, ACSL1 and ACYP1 genes. Genomic DNA isolated from liver
samples of Q10H2 supplemented (14, 17, 20, 23) and non supplemented control mice (38, 41, 44, 47) was analyzed for methylation status of 553
(sense and antisense) CpG sites of the (A) ABCA1, (B) ACSL1 and (C) ACYP1 gene promoter. Exemplary data for one amplicon of each gene is shown.
The coloured dots indicate the software determined methylation ratio at each analyzed CpG unit for each sample. nc_001 represents the reaction
negative control (water) and DNA meth the artificially completely methylated control DNA. The reference sequence above the epigram corresponds
to the genomic sequence of the analyzed strand. Displayed is the sense orientation in 5' → 3' direction. Base numbering in the epigram refers to the
analyzed amplicon.doi: 10.3164/jcbn.11 19
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